Cigna is walking away from the Affordable Care Act individual exchange business at the end of 2026. At the same time, the company is reporting a strong first-quarter profit of $1.65 billion. Together, these announcements signal a major strategic shift for one of the country’s largest health insurers.
Cigna Exits ACA Individual Market by Year-End
Cigna’s incoming CEO, Brian Evanko, confirmed the exit during the company’s April 30 first-quarter earnings call. He acknowledged that this was not a hasty decision. “We did not make this decision lightly,” Evanko said. Importantly, he added that the exit will bring no network or coverage changes for current members.
Who Is Affected by the Exit?
Cigna currently covers approximately 369,000 individuals and families through its ACA exchange plans. Moreover, these members will need to seek alternative coverage once the company fully exits the market. While the transition may seem abrupt, Cigna has assured that plan protections remain in place through the end of the year.
Why Cigna Is Leaving the Exchange Business
Cigna’s ACA exit follows a broader pattern of strategic divestment. Earlier in 2025, the company sold its Medicare Advantage business to Health Care Service Corporation (HCSC) in a $3.3 billion transaction. Evanko explained that this divestment “enabled greater focus and investment in the remaining businesses within our portfolio, supporting our forward-looking growth path.”
A Shift Toward Core Strengths
By shedding its government-sponsored individual coverage lines, Cigna is clearly doubling down on its commercial and pharmacy benefit management segments. This move narrows the company’s focus toward higher-margin, employer-facing health services. Consequently, both Evernorth and Cigna Healthcare are expected to receive increased investment and operational attention going forward.
Strong Q1 2026 Financial Results
Despite its exit announcements, Cigna posted impressive first-quarter financials. The company reported a net profit of $1.65 billion for the three months ended March 31, 2026. Furthermore, profit rose 25% year over year, reflecting the positive impact of its leaner, more focused operating model.
Total Revenue and Adjusted Income
Total revenue for Q1 2026 reached $68.5 billion, a 5% increase from the same period in 2025. Additionally, adjusted income from operations came in just under $2.1 billion, marking a 12% year-over-year improvement. These figures demonstrate that Cigna’s restructuring strategy is already generating measurable financial gains.
Evernorth Division Drives Revenue Growth
Cigna’s pharmacy and care services arm, Evernorth, continued to perform strongly in the first quarter. Total Evernorth revenue climbed 9% year over year to $58.4 billion. Furthermore, operational income from this segment reached $1.3 billion, up 18% compared to Q1 2025. Evernorth remains the company’s most significant revenue driver and appears well-positioned for continued expansion.
Cigna Healthcare Segment Performance
In contrast, Cigna Healthcare reported total revenue of just under $11.5 billion — a 21% year-over-year decline. However, this drop is largely attributable to the sale of the Medicare Advantage business to HCSC. Excluding that transaction, the segment’s underlying performance remains relatively stable. Operational income for Cigna Healthcare hit approximately $1.5 billion in the first quarter, a 12% increase over the prior year.
Medical Loss Ratio Improves Significantl
Cigna’s medical loss ratio (MLR) improved to 79.8% in Q1 2026, down 240 basis points from the first quarter of 2025. A lower MLR generally indicates that the insurer is spending a smaller share of premium revenue on medical claims, which is a positive financial signal. Cigna attributed this improvement, in part, to the removal of the Medicare Advantage business following the HCSC transaction.
Membership Grows and 2026 Outlook Rises
Member Count Edges Higher
Despite the planned ACA exit, Cigna’s total membership grew modestly. The company served 18.3 million members in Q1 2026, up from 18 million in the same quarter a year earlier. This indicates that growth in its commercial and employer segments is offsetting the anticipated loss of exchange market enrollees.
Raised Full-Year Guidance
Looking ahead, Cigna raised its full-year 2026 guidance for adjusted income from operations to at least $30.35 per share. This represents a $0.10 increase from the company’s prior projection. Analysts and investors are likely to view the upward revision as a sign of management confidence in Cigna’s restructured business model.
What This Means for the Payer Landscape
Cigna’s dual announcement — a profitable quarter paired with an ACA exit — reflects a broader industry trend. Major payers are retreating from high-cost, low-margin government markets and refocusing on commercial lines. As a result, the ACA marketplace may see fewer insurer options in some regions, raising questions about competition, premium pricing, and consumer choice in 2027 and beyond.
